Investigational Site Number 8400012 — Kansas City, Kansas

Investigational Site Number 8400012 is a clinical research site located in Kansas City, Kansas, United States 66160-7321.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site Number 8400012 has participated in 1 clinical trials.

Therapeutic areas: Glycogen Storage Disease Type II;Pompe's Disease.

Sponsors: Genzyme, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 8400012?

Investigational Site Number 8400012 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 8400012 conducted?

Investigational Site Number 8400012 has 1 clinical trials on record. Their work covers Glycogen Storage Disease Type II;Pompe's Disease.

Is Investigational Site Number 8400012 accredited by Crixeo Health?

Investigational Site Number 8400012 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 8400012?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.